Variant report

Variant	nsv891271
Chromosome Location	chr8:110054427-110101683
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:424)
CpG islands
(count:488)
Chromatin interactive
region (count:8)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:424 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr8:110078075-110078690	K562	blood:	n/a	n/a
2	ARID3A	chr8:110076210-110076604	K562	blood:	n/a	n/a
3	ARID3A	chr8:110084674-110084872	K562	blood:	n/a	chr8:110084769-110084785
4	ATF1	chr8:110078044-110078293	K562	blood:	n/a	n/a
5	ATF2	chr8:110064596-110065146	GM12878	blood:	n/a	n/a
6	ATF3	chr8:110076282-110076655	K562	blood:	n/a	n/a
7	BACH1	chr8:110084658-110085028	H1-hESC	embryonic stem cell:	n/a	chr8:110084846-110084860
8	BACH1	chr8:110084678-110085051	K562	blood:	n/a	chr8:110084846-110084860
9	BATF	chr8:110064802-110065084	GM12878	blood:	n/a	n/a
10	BATF	chr8:110064524-110065098	GM12878	blood:	n/a	n/a
11	BCL11A	chr8:110064491-110065070	GM12878	blood:	n/a	n/a
12	BCL11A	chr8:110064833-110065052	GM12878	blood:	n/a	n/a
13	BCL3	chr8:110064416-110065174	A549	lung:	n/a	n/a
14	BHLHE40	chr8:110071027-110071336	K562	blood:	n/a	n/a
15	BHLHE40	chr8:110099056-110099077	A549	lung:	n/a	n/a
16	BHLHE40	chr8:110077970-110078297	K562	blood:	n/a	n/a
17	CBX3	chr8:110054329-110054749	HCT-116	colon:	n/a	n/a
18	CBX3	chr8:110054280-110054853	HCT-116	colon:	n/a	n/a
19	CBX3	chr8:110076273-110076662	K562	blood:	n/a	n/a
20	CCNT2	chr8:110078073-110078335	K562	blood:	n/a	n/a
21	CCNT2	chr8:110071310-110071531	K562	blood:	n/a	n/a
22	CEBPB	chr8:110094703-110095199	ECC-1	luminal epithelium:	n/a	chr8:110094822-110094833
23	CEBPB	chr8:110093901-110093999	HepG2	liver:	n/a	chr8:110093920-110093931
24	CEBPB	chr8:110054169-110054813	HCT-116	colon:	n/a	chr8:110054706-110054719
25	CEBPB	chr8:110100925-110100968	A549	lung:	n/a	n/a
26	CEBPB	chr8:110080497-110080820	HepG2	liver:	n/a	n/a
27	CEBPB	chr8:110055096-110055252	K562	blood:	n/a	n/a
28	CEBPB	chr8:110100855-110100997	K562	blood:	n/a	chr8:110100916-110100927 chr8:110100916-110100925
29	CEBPB	chr8:110054457-110054714	A549	lung:	n/a	n/a
30	CEBPB	chr8:110076028-110076309	K562	blood:	n/a	n/a
31	CEBPB	chr8:110064588-110065209	A549	lung:	n/a	n/a
32	CEBPB	chr8:110066356-110066556	HepG2	liver:	n/a	chr8:110066448-110066459
33	CEBPB	chr8:110066290-110066533	A549	lung:	n/a	chr8:110066448-110066459
34	CEBPB	chr8:110064493-110065231	A549	lung:	n/a	n/a
35	CEBPB	chr8:110064568-110065141	A549	lung:	n/a	n/a
36	CEBPB	chr8:110094761-110095166	Hela-S3	cervix:	n/a	chr8:110094822-110094833
37	CEBPB	chr8:110054256-110054810	A549	lung:	n/a	chr8:110054706-110054719
38	CEBPB	chr8:110054992-110055315	A549	lung:	n/a	n/a
39	CEBPB	chr8:110088679-110088882	HepG2	liver:	n/a	n/a
40	CEBPB	chr8:110054884-110055432	A549	lung:	n/a	n/a
41	CEBPB	chr8:110055008-110055311	A549	lung:	n/a	n/a
42	CEBPD	chr8:110076207-110076660	K562	blood:	n/a	n/a
43	CEBPD	chr8:110076204-110076617	K562	blood:	n/a	n/a
44	CEBPD	chr8:110078024-110078391	K562	blood:	n/a	n/a
45	CEBPD	chr8:110071053-110071507	K562	blood:	n/a	n/a
46	CEBPD	chr8:110077956-110078408	K562	blood:	n/a	n/a
47	CHD1	chr8:110064544-110064671	GM12878	blood:	n/a	n/a
48	CHD2	chr8:110064470-110065029	GM12878	blood:	n/a	n/a
49	CTCF	chr8:110083360-110083510	GM12873	blood:	n/a	n/a
50	CTCF	chr8:110083340-110083490	GM06990	blood:	n/a	n/a

(count:488 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr8:110100005-110100055	SKMC	muscle:	n/a
2	chr8:110082656-110082706	SKMC	muscle:	n/a
3	chr8:110099750-110099800	U87	brain:	n/a
4	chr8:110099683-110099733	U87	brain:	n/a
5	chr8:110100005-110100055	BE2_C	brain:	n/a
6	chr8:110099750-110099800	PFSK-1	brain:	n/a
7	chr8:110100005-110100055	HIPEpiC	eye:	n/a
8	chr8:110099683-110099733	HAEpiC	amniotic membrane:	n/a
9	chr8:110099683-110099733	K562	blood:	n/a
10	chr8:110098844-110098894	HL-60	blood:	n/a
11	chr8:110098923-110098973	AG04450	lung:	fetal
12	chr8:110098844-110098894	HepG2	liver:	n/a
13	chr8:110098923-110098973	AG10803	skin:	n/a
14	chr8:110082656-110082706	AG09319	gingival:	n/a
15	chr8:110098844-110098894	HCT-116	colon:	n/a
16	chr8:110099750-110099800	HUVEC	blood vessel:	n/a
17	chr8:110099750-110099800	Jurkat	blood:	n/a
18	chr8:110082656-110082706	PFSK-1	brain:	n/a
19	chr8:110098866-110098916	HCM	heart:	n/a
20	chr8:110098844-110098894	NB4	blood:	n/a
21	chr8:110098923-110098973	PANC-1	pancreas:	n/a
22	chr8:110099582-110099632	T-47D	breast:	n/a
23	chr8:110099582-110099632	Caco-2	colon:	n/a
24	chr8:110099750-110099800	SK-N-MC	brain:	n/a
25	chr8:110082656-110082706	HRCEpiC	kidney:	n/a
26	chr8:110098923-110098973	MCF10A-Er-Src	breast:	n/a
27	chr8:110099750-110099800	AG04449	skin:	fetal
28	chr8:110098923-110098973	NH-A	brain:	n/a
29	chr8:110099683-110099733	T-47D	breast:	n/a
30	chr8:110099750-110099800	HEK293	kidney:	embryo
31	chr8:110098844-110098894	HCPEpiC	choroid plexus:	n/a
32	chr8:110082656-110082706	Hela-S3	cervix:	n/a
33	chr8:110098866-110098916	Hepatocyte	liver:	n/a
34	chr8:110098923-110098973	GM12878	blood:	n/a
35	chr8:110082656-110082706	AG04450	lung:	fetal
36	chr8:110100005-110100055	T-47D	breast:	n/a
37	chr8:110099582-110099632	HCT-116	colon:	n/a
38	chr8:110099750-110099800	HepG2	liver:	n/a
39	chr8:110099750-110099800	HL-60	blood:	n/a
40	chr8:110099582-110099632	GM06990	blood:	n/a
41	chr8:110098866-110098916	NHDF-neo	bronchial:	n/a
42	chr8:110099683-110099733	H1-hESC	embryonic stem cell:	embryo
43	chr8:110098866-110098916	AG04449	skin:	fetal
44	chr8:110100005-110100055	GM12892	blood:	n/a
45	chr8:110100005-110100055	HNPCEpiC	eye:	n/a
46	chr8:110082656-110082706	Caco-2	colon:	n/a
47	chr8:110082656-110082706	NHDF-neo	bronchial:	n/a
48	chr8:110082656-110082706	HRPEpiC	eye:	n/a
49	chr8:110098923-110098973	HUVEC	blood vessel:	n/a
50	chr8:110099683-110099733	RPTEC	kidney:	n/a

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr8:110064627..110066916-chr8:110068551..110070751,3	K562	blood:
2	chr8:110070694..110072266-chr8:110073492..110075488,2	K562	blood:
3	chr8:110084963..110087132-chr8:110090550..110092121,2	MCF-7	breast:
4	chr8:110084963..110087132-chr8:110090550..110092121,2	MCF-7	breast:
5	chr8:110070694..110072266-chr8:110073492..110075488,2	K562	blood:
6	chr8:110077392..110079634-chr8:110134593..110136611,2	K562	blood:
7	chr8:110064627..110066916-chr8:110068551..110070751,3	K562	blood:
8	chr8:110096767..110098879-chr8:110100924..110103388,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TMEM74-1	chr8:110055906-110055968	ENSG00000253796.1
2	lnc-TMEM74-1	chr8:110075518-110075646	ENSG00000253796.1
3	lnc-TMEM74-1	chr8:110056285-110056356	ENSG00000253796.1

No data

Variant related genes	Relation type
TRHR	TF binding region
ENSG00000253796	TF binding region
TRHR	CpG island
ENSG00000253796	CpG island
ENSG00000174417	chromatin interactions

Extended variants
information (count: 1673 )
Associated
traits (count: 97 )

Variant overlapped rSNPs/rCNVs (count:1673 , 50 per page) page: 1 2 3 4 5 6 7 ... 34

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs4332103	chr8:110054427-110054428	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs190379518	chr8:110054434-110054435	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs565991432	chr8:110054609-110054610	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs535127053	chr8:110054621-110054622	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs551621559	chr8:110054702-110054703	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs375639679	chr8:110054704-110054705	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs200029464	chr8:110054743-110054744	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs372853393	chr8:110054745-110054746	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs78676714	chr8:110054758-110054759	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs529590849	chr8:110054789-110054790	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs77156130	chr8:110054797-110054798	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs112955461	chr8:110054906-110054907	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs148786512	chr8:110054995-110054996	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs535396260	chr8:110055035-110055036	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs369736056	chr8:110055173-110055174	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs143907456	chr8:110055203-110055204	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs201779364	chr8:110055206-110055207	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs146395857	chr8:110055214-110055215	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs72052004	chr8:110055215-110055216	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs555352901	chr8:110055233-110055234	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs571989315	chr8:110055242-110055243	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs193296699	chr8:110055274-110055275	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs564054546	chr8:110055298-110055299	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs550143671	chr8:110055312-110055313	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs578112043	chr8:110055324-110055325	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs543623720	chr8:110055332-110055333	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs79974404	chr8:110055366-110055367	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs529544637	chr8:110055399-110055400	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs142459652	chr8:110055400-110055401	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs559688002	chr8:110055412-110055413	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs528521417	chr8:110055447-110055448	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs551829701	chr8:110055451-110055452	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs4620260	chr8:110055453-110055454	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
34	rs562841475	chr8:110055475-110055476	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs377534932	chr8:110055491-110055492	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs550006083	chr8:110055502-110055503	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs569927678	chr8:110055511-110055512	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs535740721	chr8:110055519-110055520	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs555423069	chr8:110055535-110055536	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs565648431	chr8:110055563-110055564	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs534357127	chr8:110055606-110055607	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs557800917	chr8:110055639-110055640	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs77390957	chr8:110055669-110055670	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs74601301	chr8:110055670-110055671	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs6469224	chr8:110055687-110055688	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
46	rs543561079	chr8:110055688-110055689	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs372640935	chr8:110055722-110055723	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs9693459	chr8:110055827-110055828	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs573937039	chr8:110055832-110055833	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs543299893	chr8:110055842-110055843	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:97)

Disease	PMID	Source
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Ewing''s sarcoma	21437220	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Gastric cancer	17908304	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Seminomas	18059402	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Pancreatic cancer	21811587	CNVD
Thyroid cancer	19087340	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	17603634	CNVD
Testicular cancer	18059402	CNVD
Breast cancer	17133270	CNVD
Breast cancer	21509527	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Cancer	20164919	CNVD
abnormal development	18461090	CNVD
Oral cancer	21386901	CNVD
Uveal melanoma	21693616	CNVD
Langer-Giedion syndrome	22283845	CNVD
Cancer	21637783	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Breast cancer	20632083	CNVD
Breast cancer	19602461	CNVD
Cancer	22429812	CNVD
Endometrial cancer	22040021	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oral cancer	19627613	CNVD
Prostate cancer	21088497	CNVD
colon cancer	17210682	CNVD
Breast cancer	21264507	CNVD
Breast cancer	22028636	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	16751803	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Gastric cancer	17167181	CNVD
Colorectal cancer	19359472	CNVD
Breast cancer	16461572	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
head and neck squamous cell carcinoma	18028549	CNVD
Breast cancer	17001317	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ewing''s sarcoma	17952124	CNVD
Urothelial carcinoma	21177765	CNVD
Lung cancer	18438408	CNVD
Breast cancer	16608533	CNVD
Metanephric adenoma	20802469	CNVD
Hepatocellular carcinoma	18803288	CNVD
Prostate cancer	18632612	CNVD
Ovarian cancer	22174824	CNVD
Prostate cancer	16573809	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Adenocarcinoma	21044232	CNVD
Squamous cell cancer	20885788	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	16461572	CNVD
Breast cancer	21399628	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	17393978	CNVD
Burkitt''s lymphoma	18698080	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Breast cancer	17899364	CNVD
Acute myeloid leukemia	21251322	CNVD
Colorectal cancer	16774939	CNVD
Autosomal-dominant progressive external ophthalmoplegia	19664747	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Multiple myeloma	16461302	CNVD
Sezary syndrome	18413736	CNVD
Breast cancer	21611746	CNVD
Developmental delay	21147756	CNVD
Congenital diaphragmatic hernia	21525063	CNVD
Breast cancer	21364760	CNVD
Gastric cancer	22539939	CNVD
Non-small cell lung cancer	19010865	CNVD
small cell lung cancer	20016488	CNVD
Oral squamous cell carcinoma	21853135	CNVD
Chronic myeloid leukemia	21384125	CNVD
Prostate cancer	22341455	CNVD

Chromatin state (count:105 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:110052800-110055200	Enhancers	HMEC	breast
2	chr8:110052800-110055400	Enhancers	HSMM	muscle
3	chr8:110054000-110054600	Enhancers	Stomach Mucosa	stomach
4	chr8:110054000-110054800	Flanking Active TSS	A549	lung
5	chr8:110054200-110054600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
6	chr8:110054200-110054600	Enhancers	HUES48 Cell Line	embryonic stem cell
7	chr8:110054200-110054600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
8	chr8:110054200-110054600	Flanking Active TSS	Muscle Satellite Cultured Cells	--
9	chr8:110054200-110054600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
10	chr8:110054200-110054600	Enhancers	Hela-S3	cervix
11	chr8:110054200-110054600	Flanking Active TSS	NH-A	brain
12	chr8:110054200-110054800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
13	chr8:110054200-110055000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
14	chr8:110054200-110055000	Flanking Active TSS	HUVEC	blood vessel
15	chr8:110054200-110055000	Enhancers	NHEK	skin
16	chr8:110054200-110055200	Enhancers	Osteobl	bone
17	chr8:110054400-110064200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
18	chr8:110054600-110055000	Weak transcription	Stomach Mucosa	stomach
19	chr8:110054600-110055400	Enhancers	NH-A	brain
20	chr8:110054600-110055600	Enhancers	Muscle Satellite Cultured Cells	--
21	chr8:110054800-110055800	Enhancers	A549	lung
22	chr8:110055000-110055400	Enhancers	Stomach Mucosa	stomach
23	chr8:110055000-110055400	Enhancers	HUVEC	blood vessel
24	chr8:110059400-110059800	Active TSS	HSMMtube	muscle
25	chr8:110063800-110064000	Enhancers	A549	lung
26	chr8:110064000-110064600	Flanking Active TSS	A549	lung
27	chr8:110064200-110064800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
28	chr8:110064200-110065000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
29	chr8:110064600-110065000	Enhancers	NH-A	brain
30	chr8:110064600-110065200	Active TSS	A549	lung
31	chr8:110064600-110065400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
32	chr8:110065000-110077800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
33	chr8:110065200-110065400	Flanking Active TSS	A549	lung
34	chr8:110065400-110066400	Enhancers	A549	lung
35	chr8:110066400-110067600	Weak transcription	A549	lung
36	chr8:110067600-110067800	Enhancers	A549	lung
37	chr8:110074800-110079000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
38	chr8:110075000-110075200	Enhancers	Primary hematopoietic stem cells	blood
39	chr8:110075000-110078800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
40	chr8:110075000-110083400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
41	chr8:110075200-110076000	Enhancers	GM12878-XiMat	blood
42	chr8:110075400-110077000	Enhancers	Primary hematopoietic stem cells short term culture	blood
43	chr8:110075600-110075800	Enhancers	K562	blood
44	chr8:110075800-110076600	Weak transcription	K562	blood
45	chr8:110076000-110076800	Active TSS	GM12878-XiMat	blood
46	chr8:110076000-110076800	Enhancers	Osteobl	bone
47	chr8:110076000-110077000	Enhancers	Muscle Satellite Cultured Cells	--
48	chr8:110076000-110077200	Enhancers	NH-A	brain
49	chr8:110076400-110076800	Enhancers	iPS-15b Cell Line	embryonic stem cell
50	chr8:110076400-110076800	Enhancers	iPS-18 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links